首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Binding of heparin to antithrombin III: The use of dansyl and rhodamine labels
Authors:Michael W Piepkorn  David Lagunoff  Gottfried Schmer
Institution:1. Department of Pathology, University of Washington, School of Medicine, Seattle, Washington 98195 U.S.A.;4. Department of Laboratory Medicine, University of Washington, School of Medicine, Seattle, Washington 98195 U.S.A.;2. Department of Biochemistry, University of Washington, School of Medicine, Seattle, Washington 98195 U.S.A.;3. Department of Medicine (Dermatology), University of Washington, School of Medicine, Seattle, Washington 98195 U.S.A.
Abstract:Low molecular weight heparin of low-anticoagulant activity and high molecular weight heparin of correspondingly high activity were prepared by chromatography on protamine-Sepharose; preparations subjected to limited N-desulfation (5–10% free amino groups) by solvolysis were labeled with 5-dimethylaminonaphthalene-1-sulfonyl chloride (dansyl chloride) or rhodamine B isothiocyanate (RITC). The fluorescent heparins retained approximately 50% of the original anticoagulant activities. Dansyl-heparin on binding to antithrombin III (ATIII) exhibited a 2.5-fold enhancement of dansyl fluorescence intensity. This effect could be prevented by excess unlabeled heparin. A 7900 molecular weight dansyl-heparin preparation bound to ATIII with a stoichiometry of close to 2:1 and with an apparent association constant for binding (Ka) of 4.9 × 105, m?1, whereas a 21,600 molecular weight fraction bound at 0.7:1 with the protein and with an apparent Ka = 7.9 × 105, m?1. When ATIII reacted with a mixture of low molecular weight dansyl-heparin and low molecular weight RITC-heparin, there was enhancement of RITC fluorescence emission when excited at the dansyl excitation maximum; this effect was not observed when either of the labeled heparin species was prepared from high molecular weight material. The results are consistent with the proposal that a single molecule of high molecular weight, high-activity heparin occupies two sites when it binds to ATIII, whereas low molecular weight, low-activity heparin binds to the two sites separately.
Keywords:Address reprint requests to the Department of Medicine (Dermatology)  RM-14  Health Sciences  University of Washington  Seattle  Wash  98195  
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号